查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
一氧化氮吸入輸送系統市場- 全球產業分析，規模，佔有率，成長，趨勢，及預測，2022-2031年
市場調查報告書
商品編碼
1229624

一氧化氮吸入輸送系統市場- 全球產業分析，規模，佔有率，成長，趨勢，及預測，2022-2031年

Inhaled Nitric Oxide Delivery System Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日期: | 出版商: Transparency Market Research | 英文 182 Pages | 商品交期: 2-10個工作天內

價格

本報告以2022年為基準年，以2031年為預測年，提供從2017年到2031年的一氧化氮吸入輸送系統的世界市場收益。還有從2022年到2031年的一氧化氮吸入輸送系統的全球市場的年複合成長率(CAGR%)。

本報告經由廣泛研究製作。在一手調查中，分析師對主要意見領袖、產業領袖和輿論製造者進行訪談，進行大部分的研究工作。在二次調查中，透過參考各大公司的產品資料、年報、新聞稿、相關文件等，掌握一氧化氮吸入輸送系統市場。

本報告深入研究全球一氧化氮吸入輸送系統市場競爭情形。識別一氧化氮吸入輸送系統的全球市場開展事業的主要企業，進行各企業的各種屬性側寫。介紹企業概要，財務狀況，最近的開拓，SWOT，一氧化氮吸入輸送系統的全球市場中企業的屬性。

目錄

第1章 序文

  • 市場定義和範圍
  • 市場區隔
  • 主要的調查目的
  • 調查亮點

第2章 前提條件與調查手法

第3章 摘要整理:一氧化氮吸入輸送系統的全球市場

第4章 市場概要

  • 簡介
    • 市場區隔定義
  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 一氧化氮吸入輸送系統的全球市場的分析與預測，2017-2031年
    • 市場收益預測

第5章 關鍵見解

  • 不僅是成人，概觀兒童的iNO的應用。
  • 技術的進步
  • 關於全球疾病的得病率和發生率，主要國家
  • COVID-19影響度分析

第6章 一氧化氮吸入輸送系統的全球市場分析、預測:各類型

  • 簡介和定義
  • 主要的發現、發展
  • 市場價值預測:各類型，2017年～2031年
    • 兒童
    • 成人
  • 市場魅力分析:各類型

第7章 一氧化氮吸入輸送系統的全球市場分析、預測:各用途

  • 簡介和定義
  • 主要的發現、發展
  • 市場價值預測:各應用領域，2017-2031年
    • 關於低氧性呼吸不全的處理
    • 急性血管反應性實驗(Acute Vasoreactivity Testing
    • 關於肺高血壓(PH)的治療
    • 其他
  • 市場魅力分析:各應用領域

第8章 一氧化氮吸入輸送系統的全球市場分析、預測:各終端用戶

  • 簡介和定義
  • 主要的發現、發展
  • 市場價值預測:各終端用戶，2017年～2031年
    • 醫院
    • 門診病人手術中心
    • 其他
  • 市場魅力分析:各終端用戶

第9章 一氧化氮吸入輸送系統的全球市場分析、預測:各地區

  • 主要調查結果
  • 市場價值預測:各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東
  • 市場魅力分析:各地區

第10章 北美的一氧化氮吸入輸送系統的市場分析與預測

  • 簡介
    • 主要調查結果
  • 市場價值預測:各類型，2017年～2031年
    • 兒童
    • 成人
  • 市場價值預測:各應用領域，2017-2031年
    • 關於低氧性呼吸不全的處理
    • 急性血管反應性實驗(Acute Vasoreactivity Testing
    • 關於肺高血壓(PH)的治療
    • 其他
  • 市場價值預測:各終端用戶，2017年～2031年
    • 醫院
    • 門診病人手術中心
    • 其他
  • 市場價值預測:各國，2017-2031年
    • 美國
    • 加拿大
  • 市場魅力度分析
    • 各類型
    • 各應用領域
    • 各終端用戶
    • 各國

第11章 歐洲的一氧化氮吸入輸送系統市場分析與預測

  • 簡介
    • 主要調查結果
  • 市場價值預測:各類型，2017年～2031年
    • 兒童
    • 成人
  • 市場價值預測:各應用領域，2017-2031年
    • 關於低氧性呼吸不全的處理
    • 急性血管反應性實驗(Acute Vasoreactivity Testing
    • 關於肺高血壓(PH)的治療
    • 其他
  • 市場價值預測:各終端用戶，2017年～2031年
    • 醫院
    • 門診病人手術中心
    • 其他
  • 市場價值預測:各國和各地，2017-2031年
    • 德國
    • U.K.
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲
  • 市場魅力度分析
    • 各類型
    • 各應用領域
    • 各終端用戶
    • 各國和各地

第12章 亞太地區的一氧化氮吸入輸送系統市場分析與預測

  • 簡介
    • 主要調查結果
  • 市場價值預測:各類型，2017年～2031年
    • 兒童
    • 成人
  • 市場價值預測:各應用領域，2017-2031年
    • 關於低氧性呼吸不全的處理
    • 急性血管反應性實驗(Acute Vasoreactivity Testing
    • 關於肺高血壓(PH)的治療
    • 其他
  • 市場價值預測:各終端用戶，2017年～2031年
    • 醫院
    • 門診病人手術中心
    • 其他
  • 市場價值預測:各國和各地，2017-2031年
    • 中國
    • 日本
    • 印度
    • 澳洲、紐西蘭
    • 其他亞太地區
  • 市場魅力度分析
    • 各類型
    • 各應用領域
    • 各終端用戶
    • 各國和各地

第13章 南美一氧化氮吸入輸送系統市場分析與預測

  • 簡介
    • 主要調查結果
  • 市場價值預測:各類型，2017年～2031年
    • 兒童
    • 成人
  • 市場價值預測:各應用領域，2017-2031年
    • 關於低氧性呼吸不全的處理
    • 急性血管反應性實驗(Acute Vasoreactivity Testing
    • 關於肺高血壓(PH)的治療
    • 其他
  • 市場價值預測:各終端用戶，2017年～2031年
    • 醫院
    • 門診病人手術中心
    • 其他
  • 市場價值預測:各國和各地，2017-2031年
    • 巴西
    • 墨西哥
    • 其他南美國家地區
  • 市場魅力度分析
    • 各類型
    • 各應用領域
    • 各終端用戶
    • 各國和各地

第14章 中東的一氧化氮吸入輸送系統市場分析與預測

  • 簡介
    • 主要調查結果
  • 市場價值預測:各類型，2017年～2031年
    • 兒童
    • 成人
  • 市場價值預測:各應用領域，2017-2031年
    • 關於低氧性呼吸不全的處理
    • 急性血管反應性實驗(Acute Vasoreactivity Testing
    • 關於肺高血壓(PH)的治療
    • 其他
  • 市場價值預測:各終端用戶，2017年～2031年
    • 醫院
    • 門診病人手術中心
    • 其他
  • 市場價值預測:各國和各地，2017-2031年
    • GCC各國
    • 南非
    • 其他中東、南非地區
  • 市場魅力度分析
    • 各類型
    • 各應用領域
    • 各終端用戶
    • 各國和各地

第15章 競爭情形

  • 市場企業-競爭矩陣(各等級，各企業規模)
  • 市場佔有率分析:各企業，2021年
  • 企業簡介
    • Mallinckrodt
    • Santair AE
    • VERO Biotech
    • Linde plc
    • Beyond Air, Inc.
    • SLE
    • Bellerophon Therapeutics
    • Air Liquide Healthcare
    • International Biomedical
    • Circassia Pharmaceuticals
Product Code: TMRGL85332

The report provides revenue of the global inhaled nitric oxide delivery system market for the period 2017-2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global inhaled nitric oxide delivery system market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the inhaled nitric oxide delivery system market.

The report delves into the competitive landscape of the global inhaled nitric oxide delivery system market. Key players operating in the global inhaled nitric oxide delivery system market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global inhaled nitric oxide delivery system market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Inhaled Nitric Oxide Delivery System Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Inhaled Nitric Oxide Delivery System Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Overview of applications of iNO in pediatric as well as in adults
  • 5.2. Technological Advancements
  • 5.3. Disease prevalence and incidence globally with key countries
  • 5.4. Covid-19 Impact Analysis

6. Global Inhaled Nitric Oxide Delivery System Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Type, 2017-2031
    • 6.3.1. Pediatric
    • 6.3.2. Adult
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Inhaled Nitric Oxide Delivery System Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Hypoxemic Respiratory Failure Treatment
    • 7.3.2. Acute Vasoreactivity Testing
    • 7.3.3. Pulmonary Hypertension (PH) Treatment
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Inhaled Nitric Oxide Delivery System Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. Ambulatory Surgical Centers
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Inhaled Nitric Oxide Delivery System Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Inhaled Nitric Oxide Delivery System Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Type, 2017-2031
    • 10.2.1. Pediatric
    • 10.2.2. Adult
  • 10.3. Market Value Forecast, by Application, 2017-2031
    • 10.3.1. Hypoxemic Respiratory Failure Treatment
    • 10.3.2. Acute Vasoreactivity Testing
    • 10.3.3. Pulmonary Hypertension (PH) Treatment
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Hospitals
    • 10.4.2. Ambulatory Surgical Centers
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Inhaled Nitric Oxide Delivery System Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Type, 2017-2031
    • 11.2.1. Pediatric
    • 11.2.2. Adult
  • 11.3. Market Value Forecast, by Application, 2017-2031
    • 11.3.1. Hypoxemic Respiratory Failure Treatment
    • 11.3.2. Acute Vasoreactivity Testing
    • 11.3.3. Pulmonary Hypertension (PH) Treatment
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Hospitals
    • 11.4.2. Ambulatory Surgical Centers
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Inhaled Nitric Oxide Delivery System Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2017-2031
    • 12.2.1. Pediatric
    • 12.2.2. Adult
  • 12.3. Market Value Forecast, by Application, 2017-2031
    • 12.3.1. Hypoxemic Respiratory Failure Treatment
    • 12.3.2. Acute Vasoreactivity Testing
    • 12.3.3. Pulmonary Hypertension (PH) Treatment
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Hospitals
    • 12.4.2. Ambulatory Surgical Centers
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Inhaled Nitric Oxide Delivery System Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type, 2017-2031
    • 13.2.1. Pediatric
    • 13.2.2. Adult
  • 13.3. Market Value Forecast, by Application, 2017-2031
    • 13.3.1. Hypoxemic Respiratory Failure Treatment
    • 13.3.2. Acute Vasoreactivity Testing
    • 13.3.3. Pulmonary Hypertension (PH) Treatment
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Hospitals
    • 13.4.2. Ambulatory Surgical Centers
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East Inhaled Nitric Oxide Delivery System Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type, 2017-2031
    • 14.2.1. Pediatric
    • 14.2.2. Adult
  • 14.3. Market Value Forecast, by Application, 2017-2031
    • 14.3.1. Hypoxemic Respiratory Failure Treatment
    • 14.3.2. Acute Vasoreactivity Testing
    • 14.3.3. Pulmonary Hypertension (PH) Treatment
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. Hospitals
    • 14.4.2. Ambulatory Surgical Centers
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & South Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company, 2021
  • 15.3. Company Profiles
    • 15.3.1. Mallinckrodt
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Santair AE
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. VERO Biotech
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Linde plc
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Beyond Air, Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. SLE
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Bellerophon Therapeutics
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Air Liquide Healthcare
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. International Biomedical
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Circassia Pharmaceuticals
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments

List of Tables

  • Table 01: Global Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 02: Global Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 03: Global Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 07: North America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 08: North America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 11: Europe Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 12: Europe Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Asia Pacific Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 15: Asia Pacific Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 16: Asia Pacific Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Latin America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 19: Latin America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Material 2017-2031
  • Table 20: Latin America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 23: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 24: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Inhaled Nitric Oxide Delivery System Market Value Share, by Type, 2021
  • Figure 03: Global Inhaled Nitric Oxide Delivery System Market Value Share, by Application, 2021
  • Figure 04: Global Inhaled Nitric Oxide Delivery System Market Value Share, by End-user, 2021
  • Figure 05: Global Inhaled Nitric Oxide Delivery System Market Value Share, by Region, 2021
  • Figure 06: Global Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Type, 2021 and 2031
  • Figure 07: Global Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Type, 2022-2031
  • Figure 08: Global Inhaled Nitric Oxide Delivery System Market Value (US$ Mn), by Pediatric, 2017-2031
  • Figure 09: Global Inhaled Nitric Oxide Delivery System Market Value (US$ Mn), by Adult, 2017-2031
  • Figure 10: Global Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 11: Global Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 12: Global Inhaled Nitric Oxide Delivery System Market Revenue (US$ Mn), by Hypoxemic Respiratory Failure Treatment, 2017-2031
  • Figure 13: Global Inhaled Nitric Oxide Delivery System Market Revenue (US$ Mn), by Acute Vasoreactivity Testing, 2017-2031
  • Figure 14: Global Inhaled Nitric Oxide Delivery System Market Revenue (US$ Mn), by Pulmonary Hypertension (PH) Treatment, 2017-2031
  • Figure 15: Global Inhaled Nitric Oxide Delivery System Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 16: Global Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by End-user 2021 and 2031
  • Figure 17: Global Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by End-user 2022-2031
  • Figure 18: Global Inhaled Nitric Oxide Delivery System Market Revenue (US$ Mn), by Hospitals, 2017-2031
  • Figure 19: Global Inhaled Nitric Oxide Delivery System Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2017-2031
  • Figure 20: Global Inhaled Nitric Oxide Delivery System Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 21: Global Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 22: Global Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 23: North America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 24: North America Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 25: North America Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Country, 2022-2031 
  • Figure 26: North America Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Type, 2021 and 2031
  • Figure 27: North America Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Type 2022-2031
  • Figure 28: North America Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 29: North America Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Application 2022-2031
  • Figure 30: North America Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 31: North America Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 32: Europe Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 33: Europe Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 34: Europe Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 35: Europe Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Type, 2021 and 2031
  • Figure 36: Europe Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Type, 2022-2031
  • Figure 37: Europe Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Application 2021 and 2031
  • Figure 38: Europe Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Application 2022-2031
  • Figure 39: Europe Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 40: Europe Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 41: Asia Pacific Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 42: Asia Pacific Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 43: Asia Pacific Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 44: Asia Pacific Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Type, 2021 and 2031
  • Figure 45: Asia Pacific Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Type, 2022-2031
  • Figure 46: Asia Pacific Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 47: Asia Pacific Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 48: Asia Pacific Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 49: Asia Pacific Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 50: Latin America Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 51: Latin America Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 52: Latin America Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 53: Latin America Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Type, 2021 and 2031
  • Figure 54: Latin America Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Type, 2022-2031
  • Figure 55: Latin America Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 56: Latin America Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 57: Latin America Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 58: Latin America Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 59: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 60: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 61: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 62: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Type, 2021 and 2031
  • Figure 63: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Type, 2022-2031
  • Figure 64: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 65: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 66: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 67: Middle East & Africa Inhaled Nitric Oxide Delivery System Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 68: Company Share Analysis